Vorinostat (CAS 149647-78-9) HDAC Inhibitor API

Vorinostat (CAS 149647-78-9) is a high-purity HDAC inhibitor API with a targeted epigenetic regulatory mechanism, blocking histone deacetylase activity to modulate tumor suppressor gene expression and inhibit cancer cell proliferation. Its refined crystalline form ensures consistent bioactivity and low impurity profiles, making it a reliable active ingredient for oncology pharmaceutical R&D.

Tailored for pharmaceutical manufacturers and cancer research institutions, this product adheres to strict international quality and regulatory standards. It addresses the core demand for epigenetic-targeted raw materials, supporting the development of formulations for hematological malignancy and solid tumor research. Its stable chemical structure guarantees extended shelf life, facilitating flexible formulation design for oral preparations and clinical trial applications.